The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—General
Sichuan Kelun Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.41% CNY33.95
America/New_York / 30 apr 2024 @ 03:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 54 374 mill |
| EPS: | 1.730 |
| P/E: | 19.62 |
| Earnings Date: | May 15, 2024 |
| SharesOutstanding: | 1 601.59 mill |
| Avg Daily Volume: | 17.06 mill |
| RATING 2024-04-30 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.55x |
| Company: PE 19.62 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.35x |
| Company: PE 19.62 | industry: PE 55.30 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY69.13 (103.61%) CNY35.18 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 33.02 - 34.88 ( +/- 2.73%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY33.95 (3.41% ) |
| Volume | 23.11 mill |
| Avg. Vol. | 17.06 mill |
| % of Avg. Vol | 135.43 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 002422.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
002422.SZ
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers IV solutions; injectable powder and small volume parenteral; oral preparation; intermediates and APIs; and peritoneal dialysis solutions. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Industry Group CO., LTD.